Kung Winston 4
4 · PMV Pharmaceuticals, Inc. · Filed Apr 21, 2022
Insider Transaction Report
Form 4
Kung Winston
COO, CFO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-04-20−4,000→ 210,034 totalExercise: $3.22Exp: 2028-02-21→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2022-04-20$3.22/sh+4,000$12,880→ 10,600 total
Holdings
- 237,412(indirect: See footnote)
Stock Option (right to buy)
Exercise: $3.22Exp: 2028-02-21→ Common Stock (237,412 underlying)
Footnotes (3)
- [F1]The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.
- [F2]All of the shares subject to the option are vested and immediately exercisable.
- [F3]The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.